Similar Articles
Different Guillain-Barré Syndrome Variants Associated with COVID-19: Report of 4 Clinical Cases
Zeynep Ünlütürk, Çağatay Hilmi Öncel, Barış Haytı, Çağdaş Erdoğan
DOI: 10.4274/tnd.2021.86094
Issue: 2022, Volume 28 - Issue 1
340
357
Factors Associated with Prognosis in Patients with Guillain-Barré Syndrome
Mustafa Çetiner, Murat Seyit, Gönül Akdağ, Hayri Demirbaş, Özge Temel, Sibel Canbaz Kabay
DOI: 10.4274/tnd.2019.34445
Issue: 2019, Volume 25 - Issue 3
0
261
Differential Diagnosis Approach to Bilateral Peripheral Facial Paralysis: A Case Report
Nihan Hande Akçakaya, Meltem Hale Alpsan Gökmen, Yeşim Gülşen Parman, Feza Deymeer, Piraye Oflazer
DOI: 10.4274/tnd.02212
Issue: 2016, Volume 22 - Issue 4
0
247
A Rare Guillain Barre Syndrome Variant: Facial Diplegia Paresthesia
Emel Oguz Akarsu, Destina Yalçın, Reyhan Sürmeli, Ahmet Demir, Gülin Sünter, Yunus Diler
DOI: 10.4274/tnd.70456
Issue: 2015, Volume 21 - Issue 4
0
268
lntravenous lmmunoglobulin In Guillain-Barre Syndrome
Sibel K. VELİOĞLU, Cavit BOZ, Mehmet ÖZMENOĞLU
Issue: 2001, Volume 7 - Issue 1
0
160
Immunoglobulin Treatment and Electrophysiological Findings in -Guillain-Barrè Syndrome
Münevver ÇELİK, Buket OFLAZOĞLU, Hulki FORTA
Issue: 1997, Volume 3 - Issue 1-2
0
192
Guillain-Barré Syndrome with Bilateral Peripheral Facial Nerve Paralysis After COVID-19 Infection
Özgül Ocak
DOI: 10.4274/tnd.2021.78095
Issue: 2021, Volume 27 - Supplement 1
0
581
Guillain-Barré Syndrome and COVID-19 Vaccines: A Comment
Joob Beuy, Viroj Wiwanitkit
DOI: 10.4274/tnd.2021.47048
Issue: 2021, Volume 27 - Supplement 1
0
264